{{Rsnum
|rsid=2724384
|Gene=CD46
|Chromosome=1
|position=207756858
|Orientation=plus
|GMAF=0.1579
|Gene_s=CD46
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 63.4 | 32.1 | 4.5
| HCB | 97.8 | 2.2 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 74.8 | 24.5 | 0.7
| ASW | 68.4 | 28.1 | 3.5
| CHB | 97.8 | 2.2 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 72.3 | 25.7 | 2.0
| LWK | 75.5 | 23.6 | 0.9
| MEX | 50.9 | 42.1 | 7.0
| MKK | 60.3 | 32.7 | 7.1
| TSI | 64.4 | 27.7 | 7.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=22086389
|Title=The Association of CD46, SLAM and CD209 Cellular Receptor Gene SNPs with Variations in Measles Vaccine-Induced Immune Responses: A Replication Study and Examination of Novel Polymorphisms
|OA=1
}}

{{PMID Auto
|PMID=22357652
|Title=CD46 measles receptor polymorphisms influence receptor protein expression and primary measles vaccine responses in naive Australian children
|OA=1
}}

{{PMID|18598732|OA=1
}} Vaccine immunogenetics: bedside to bench to population.

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}